U.S. Pharma Stock News

NYSE:ASPN
NYSE:ASPNChemicals

A Look At Aspen Aerogels (ASPN) Valuation After Steep Losses And Manufacturing Impairment

Why Aspen Aerogels is back in focus Aspen Aerogels (ASPN) is back on investors’ radar after reporting a sharp year over year revenue decline, a large full year net loss, a sizeable impairment charge, and guidance indicating continued losses. See our latest analysis for Aspen Aerogels. The stock’s recent swings reflect this reset in expectations, with a 7 day share price return showing a 13.57% decline and a 1 year total shareholder return indicating a 59% loss, highlighting how pressure has...
NYSE:AS
NYSE:ASLuxury

Is Amer Sports (AS) Pricing In Too Much Optimism After Recent Share Price Swings?

If you are wondering whether Amer Sports at around US$37.98 is offering good value or not, you are not alone. This article is here to unpack that question clearly. The stock has had a mixed run, with a 9.5% decline over the last 7 days, a 3.7% gain over the past month, and a 27.1% return over the last year, which can change how investors think about both upside and risk. Recent news coverage has focused on Amer Sports as a consumer durables name that investors are watching for how it...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

Why MannKind (MNKD) Is Down 40.8% After Earnings Miss And New Tyvaso DPI Rival Appears

MannKind Corporation reported past fourth-quarter 2025 results with revenue rising to US$111.96 million, but swinging from prior net income to a US$15.95 million net loss, while full-year 2025 revenue increased to US$348.97 million alongside a lower net income of US$5.86 million. A key risk emerged as partner United Therapeutics recently unveiled a competing soft-mist treprostinil inhaler that could challenge MannKind’s Tyvaso DPI royalty stream, increasing uncertainty around the company’s...
NYSE:SDRL
NYSE:SDRLEnergy Services

Seadrill’s Record Safety And Contract Wins Set Stage For 2026 Earnings

Seadrill (NYSE:SDRL) reported record operational and safety performance, marking its best safety results to date. The company secured several long term contracts, including a key award in Malaysia in the deepwater segment. Management highlighted strong execution on complex offshore projects alongside ongoing market challenges such as high reactivation costs and regional softness. At a share price of $43.88, Seadrill is drawing attention as it pairs operational execution with what the...
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

Phathom Pharmaceuticals (PHAT) Is Up 10.0% After Guiding to 2026 Operating Profitability and Raising Capital

In late February 2026, Phathom Pharmaceuticals reported fourth-quarter and full-year 2025 results showing a much smaller net loss of US$21.15 million for the quarter and US$221.25 million for the year, alongside guidance for 2026 that includes expected operating profitability (excluding stock-based compensation) beginning in the third quarter. The company also strengthened its financial position through a US$130 million equity raise, reworked term loans, and ongoing uptake of its VOQUEZNA...
NYSE:ABR
NYSE:ABRMortgage REITs

Arbor Realty Trust (ABR) Dividend Coverage Concerns Reinforce Bearish Narratives

Arbor Realty Trust (ABR) just closed out FY 2025 with Q4 revenue of US$81.3 million and basic EPS of US$0.07, capping a year where trailing twelve month revenue came in at US$467.7 million and EPS at US$0.56. Over recent quarters the company has seen quarterly revenue range from US$111.1 million to US$140.7 million with EPS between US$0.12 and US$0.20, while trailing twelve month revenue has moved between US$467.7 million and US$650.4 million and EPS between US$0.56 and US$1.35. This sets the...
NasdaqGS:NTCT
NasdaqGS:NTCTCommunications

Is It Time To Reassess NetScout Systems (NTCT) After Its 30% One-Year Share Price Gain?

If you are wondering whether NetScout Systems is priced attractively right now, the recent share performance gives you a useful starting point but not the full story on value. The stock closed at US$29.21, with a 1.6% decline over the last 7 days, a 4.1% gain over 30 days, an 8.8% gain year to date, and a 29.9% return over the past year, while the 3 year and 5 year returns sit at 3.2% and 6.3% respectively. These moves come against a backdrop of ongoing interest in networking and...
NYSE:SHW
NYSE:SHWChemicals

Sherwin-Williams Extends 47-Year Dividend Streak As Income Story Evolves

Sherwin-Williams (NYSE:SHW) has approved its 47th consecutive annual dividend increase. The board decision extends a dividend growth streak that now spans nearly five decades. The move underscores the company’s ongoing focus on returning cash to shareholders. Sherwin-Williams, a major player in paints and coatings for residential, commercial, and industrial customers, now adds another year to its dividend growth record. For income focused investors, a streak of 47 consecutive annual...
NYSE:FRO
NYSE:FROOil and Gas

Frontline (NYSE:FRO) Margin Compression Challenges Bullish Earnings Growth Narrative

Frontline (NYSE:FRO) has capped FY 2025 with fourth quarter revenue of US$624.5 million and EPS of US$1.02, while trailing twelve month revenue sits at US$1.97 billion and EPS at US$1.70. The company has seen quarterly revenue move from US$425.6 million and EPS of US$0.30 in Q4 2024 to US$624.5 million and EPS of US$1.02 in Q4 2025, giving investors a clear view of how the top line and per share earnings have tracked over the past year as they weigh these results against margins and overall...
NYSE:RVTY
NYSE:RVTYLife Sciences

Revvity (RVTY) Valuation Check After Recent Share Price Weakness

If you are wondering whether Revvity's current share price offers good value or just more volatility, this article walks through the key numbers that matter. Revvity's share price last closed at US$98.31, with returns of a 2.0% decline over 7 days, an 11.5% decline over 30 days, a 0.2% gain year to date, and a 12.1% decline over the past year, adding important context before talking about value. Recent attention on Revvity has been shaped by ongoing coverage of its position in the...
NasdaqGS:FWON.K
NasdaqGS:FWON.KEntertainment

Is Formula One Group (FWON.K) Pricing Reflect Recent F1 Sponsorship And Media Momentum Accurately

If you are wondering whether Formula One Group at around US$91.59 is offering good value today, you are not alone. Many investors are asking the same question. The share price has returned 1.5% over the last week and 4.0% over the last month, while year to date it is down 6.6% and the 1-year return is a 5.0% decline. This compares with a 26.2% return over 3 years and 113.6% over 5 years. Recent coverage has focused on Formula One Group's position as the owner of the Formula 1 commercial...
NasdaqGS:CBSH
NasdaqGS:CBSHBanks

Waterford Advisors Sparks Fresh Look At Commerce Bancshares Valuation And Dividends

Waterford Advisors, LLC has opened a significant new position in Commerce Bancshares, indicating fresh institutional interest in the bank. The move highlights investor focus on NasdaqGS:CBSH during a period of weaker recent share price performance. Commerce Bancshares continues to be associated with a strong capital position and a track record of consistent dividend increases. Commerce Bancshares, traded as NasdaqGS:CBSH, last closed at $50.99, with the share price showing declines of 5.6%...
NYSE:MTZ
NYSE:MTZConstruction

MasTec Record Results And Acquisitions Reshape Growth And Backlog Outlook

MasTec (NYSE:MTZ) reported record full year results, with revenue and earnings above its prior guidance. The company highlighted a substantial increase in its contracted backlog, pointing to a fuller pipeline of future work. MasTec completed the acquisitions of NV2A and McKee Utility Contractors to build out its data center and water infrastructure construction management capabilities. For investors watching MasTec, the latest update provides fresh numbers on the company’s recent...
NYSE:FBK
NYSE:FBKBanks

FB Financial Merger Shifts Growth Focus While Valuation Shows Potential Upside

FB Financial (NYSE:FBK) has agreed to merge with Southern States Bancshares, expanding its banking footprint in Alabama and Georgia. The deal brings together two regional institutions with complementary branch networks and customer bases in the southeastern U.S. Management has outlined plans to integrate operations while focusing on market penetration, talent development and potential future acquisitions. FB Financial enters this merger with shares at $54.69 and a 1 year return of 9.9%,...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

Is It Too Late To Reassess RadNet (RDNT) After Its Strong Multi Year Share Price Run

If you are wondering whether RadNet's share price still reflects fair value after a strong multi year run, you are not alone. This article will walk through what the numbers actually say. RadNet recently closed at US$69.81, with returns of a 0.4% decline over 7 days, a 2.6% decline over 30 days, a 1.6% decline year to date, and a 25.9% gain over 1 year, as well as a very large gain over 5 years that may have reshaped expectations around risk and opportunity. Recent news around RadNet has...
NYSE:WMK
NYSE:WMKConsumer Retailing

Weis Markets Restatement Raises Questions On Valuation And Earnings Quality

Weis Markets (NYSE:WMK) has delayed filing its annual Form 10 K as it works through a restatement of historical financial statements. The restatement is tied to errors identified in inventory accounting and related internal control issues. The company is reviewing potential material weaknesses in its financial reporting processes before submitting the updated filing. Weis Markets operates a regional supermarket chain, so reliable inventory accounting is central to how investors evaluate its...
NYSE:HLF
NYSE:HLFPersonal Products

Is Herbalife (HLF) Still Attractive After 135% One Year Share Price Surge?

This article examines whether Herbalife, trading at around US$19.52, might be a bargain or a value trap by exploring what the current price could be implying about the company. The stock has had a mixed run, with a 7 day return of a 2.2% decline, a 30 day return of 18.4%, year to date gains of 52.3%, and a 1 year return of 135.2%. Over longer periods, the 3 year and 5 year returns stand at a 5.3% decline and a 58.9% decline respectively. Recent coverage of Herbalife has focused on its...
NYSE:BHC
NYSE:BHCPharmaceuticals

Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts

Why Bausch Health Companies (BHC) Is On Investors’ Radar Today Bausch Health Companies (BHC) has come into focus after recent trading left the share price around $5.93. This has prompted investors to reassess the diversified healthcare group’s mixed return profile and current valuation signals. See our latest analysis for Bausch Health Companies. The recent pullback, with a 1 day share price return of 1.82% decline and a year to date share price return of 17.75% decline, contrasts with a 1...
NYSE:BRO
NYSE:BROInsurance

Brown And Brown Taps Dori Henderson To Drive Technology And AI Shift

Brown & Brown (NYSE:BRO) has appointed Dorothea "Dori" Henderson as Chief Information Technology Officer. Henderson will lead the company’s enterprise technology strategy and digital transformation efforts. Her background includes senior technology roles at CareFirst BlueCross BlueShield and Collins Aerospace. Brown & Brown, a large insurance brokerage and risk management firm, is leaning further into technology as the sector continues to invest in digital tools, data platforms, and...
NYSE:QBTS
NYSE:QBTSSoftware

Is D-Wave Quantum (QBTS) Pricing Reflect Recent Quantum Computing Headlines And Sharp Share Swings

If you are trying to figure out whether D-Wave Quantum's share price makes sense right now, you are not alone. This article looks closely at what the current market value might be telling you about the business. The stock has been volatile, with a 4% move over the last week, a 24.8% decline over 30 days, a 33.2% decline year to date, and a 242.7% return over the past year, alongside a very large return over three years and an 85.8% return over five years. Recent headlines have focused on...
NYSE:DECK
NYSE:DECKLuxury

Deckers Guidance Hike Highlights UGG And HOKA Strength For Investors

Deckers Outdoor (NYSE:DECK) raised its financial guidance, citing record company performance. Management highlighted strong growth in both the UGG and HOKA brands as key drivers. Analyst outlook on the stock has been upgraded following the new guidance and record results. For you as an investor, the key point is that Deckers Outdoor, the company behind UGG and HOKA, is tying its higher guidance directly to brand-level momentum and record financial performance. In footwear and apparel, where...
NYSE:CUBE
NYSE:CUBESpecialized REITs

CubeSmart (CUBE) Margin Compression Challenges Income Focus Narrative After FY 2025 Results

CubeSmart (CUBE) has just wrapped up FY 2025 with fourth quarter revenue of US$282.7 million and basic EPS of US$0.34, while trailing twelve month revenue sits at US$1.1 billion and EPS at US$1.46, giving investors a clear read on the top and bottom line heading into the new year. Over recent periods, the company has seen revenue move from US$268.5 million and EPS of US$0.45 in Q4 2024 to US$282.7 million and EPS of US$0.34 in Q4 2025, alongside trailing twelve month EPS shifting from US$1.73...
NYSE:PK
NYSE:PKHotel and Resort REITs

Park Hotels Ties Finance And Operations With Sean Dell’Orto Promotion

Park Hotels & Resorts (NYSE:PK) has appointed Sean M. Dell’Orto as Chief Operating Officer, adding to his existing roles as Chief Financial Officer and Treasurer. The expanded role gives Dell’Orto broader oversight of operations alongside his current finance responsibilities. For Park Hotels & Resorts, which last closed at $11.31, this leadership shift puts one executive at the center of both financial and operational decisions. The stock shows mixed performance, with a 5.4% return over the...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

Is It Time To Reassess Immunocore (IMCR) After Recent Biotech Progress And Valuation Signals

If you are wondering whether Immunocore Holdings is priced attractively right now, this article will walk through how its current share price stacks up against several valuation checks. The stock last closed at US$32.30, with a 10.0% return over the past year but declines of 1.2% over 7 days, 2.5% over 30 days and 4.4% year to date. These movements can change how investors think about both upside potential and risk. Recent news around Immunocore has focused on its position within the...